Inventor · disambiguated record
Nicolas Guimond
Also filed as: GUIMOND NICOLAS
4 granted patents·1 pending application·32 citations·filing 2015–2017
75Inventor score
Files withBayer Pharma AG5
Top patents by PatentIndex Score
5 records- 0194US10759758B2Polymorphic form of N-{6-(hydroxypropan-2-yl)-2-[2-(methylsulphonyl)ethyl]-2H-indazol-5-yl}-6-(trifluoromethyl)pyridine-2-carboxamideBayer Pharma AG·Filed 2017·Granted Sep 1, 2020·17 cites·10 claims
- 0286US10501437B2Crystalline forms of N-[2-(3-Hydroxy-3-methylbutyl)-6-(2-hydroxypropan-2-yl)-2H-indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamideBayer Pharma AG·Filed 2017·Granted Dec 10, 2019·6 cites·12 claims
- 0384US10501417B2Synthesis of indazolesBayer Pharma AG·Filed 2017·Granted Dec 10, 2019·5 cites·22 claims
- 0483US10633365B2Synthesis of indazolesBayer Pharma AG·Filed 2017·Granted Apr 28, 2020·4 cites·28 claims
- 0529US2017305912A1Process for the preparation of 3-phenyl/heteroaryl-6-phenoxy-8-alkylamino-imidazo[1,2-b]pyridazine derivativesBayer Pharma AG·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nicolas Guimond files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →